Skip to main content
ASPN
NYSE Trade & Services

Aspen Aerogels 10-Q: Q3 Revenue $85.2M, Net Loss $10.4M, $146M Cash

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Building Materials Stocks · Materials
Sentiment info
Neutral
Importance info
7
Price
$5.16
Mkt Cap
$428.222M
52W Low
$2.3
52W High
$8.1
52W Position info
124% above low
Off High info
36% below high
Rel. Volume info
4.1× avg
Market data snapshot near publication time

ASPN has more than doubled off its 52-week low of $2.3 on elevated volume (4.1× avg).

Summary

Aspen Aerogels' Q3 10-Q confirms the $85.2M revenue beat and $10.4M net loss, with $146.0M cash and a newly disclosed CEO 10b5-1 plan covering up to 1.25M shares.


Key Events · Earnings and Guidance · ASPN

  • Q3 Revenue $85.2M, Net Loss $10.4M

    Revenue rose 17% to $85.2M from $73.0M; net loss widened to $10.4M ($0.13 per share) from $6.3M, and Adjusted EBITDA was $19.8M.

  • Thermal Barrier Slides, Energy Industrial Jumps

    Thermal Barrier revenue fell 7% to $45.3M while Energy Industrial rose 64% to $39.9M; gross margin compressed to 24% from 28% on East Providence incident costs.

  • Liquidity: $146.0M Cash, $22.2M Revolver

    Cash and equivalents were $146.0M at September 30, 2026; the term loan was paid down to $73.0M from $92.5M, and $22.2M remained available under the Revolving Facility.

  • CEO 10b5-1 Plan for 1.25M Shares

    CEO Donald R. Young adopted a Rule 10b5-1 plan on August 12, 2026 covering up to 1,251,949 shares through December 31, 2027 — a pre-scheduled selling overhang, not an executed sale.


Analysis · ASPN · Trade & Services

The 10-Q confirms the Q3 beat already reported in this morning's 8-K and adds the full financials. Revenue rose 17% to $85.2M on a 64% jump in Energy Industrial, but Thermal Barrier fell 7% and gross margin slipped to 24% from 28% as East Providence incident costs hit cost of revenue. The balance sheet is the reassuring part: $146.0M of cash plus $22.2M of revolver availability, with the term loan paid down to $73.0M. The new disclosure is a CEO 10b5-1 plan adopted August 12 covering up to 1,251,949 shares through 2027 — a pre-scheduled selling overhang, not a sale itself.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ASPN was trading at $5.16 on NYSE in the Trade & Services sector, with a market capitalization of approximately $428.2M. The 52-week trading range was $2.30 to $8.10. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ASPN - Latest Insights

ASPN
Nov 05, 2026, 6:30 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.84
Real-time Price: $4.62 info
Change: -$0.225 (-5%) info
Market Cap: $384.959M info
ASPN
Nov 05, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.11
Real-time Price: $4.62 info
Change: -$0.495 (-10%) info
Market Cap: $384.959M info
ASPN
Sep 24, 2026, 9:12 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $5.30
Real-time Price: $4.62 info
Change: -$0.685 (-13%) info
Market Cap: $384.959M info
ASPN
Sep 15, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.97
Real-time Price: $4.62 info
Change: -$0.355 (-7%) info
Market Cap: $384.959M info
ASPN
Aug 06, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.11
Real-time Price: $4.62 info
Change: -$1.50 (-24%) info
Market Cap: $384.959M info